Prometheus Biosciences Inc. (RXDX) – Analyst Comments
-
Horizon (HZNP) tumbles on potential FTC lawsuit to block Amgen deal; Analysts surprised
-
We see Merck's (MRK) deal for Prometheus as a strategic positive and another step in the right direction to diversify Keytruda concentration risk -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to RXDX Stock Lookup